Movalis Efficacy And Safety In The Treatment Of Locomotor Apparatus Diseases
Movalis efficacy and safety in the treatment of locomotor apparatus diseasesN.V. Chichasova
Movalis efficacy and safety in the treatment of locomotor apparatus diseases Treatment of chronic locomotor diseases is a complex task. Antiinflammatory and analgesic therapy are complicated by advanced age, concomitant diseases and necessity of its treatment. Frequently used classic nonsteroidal antiinflammatory drugs besides positive effects often cause adverse effects from gastrointestinal tract, liver, kidneys, bronchus, what limits the providing of adequate therapy. The cyclo-oxygenase-2 selective inhibitors meloxicam (Movalis) have the same effectiveness as classic nonsteroidal antiinflammatory drugs, but much better tolerability, including elderly people. The paper includes the results of research and clinical practice, confirming the efficiency and safety of Movalis.
Keywords
rheumatic diseases
antiinflammatory therapy
nonsteroidal antiinflammatory drugs
cyclo-oxygenase-2 selective inhibitors
adverse events
meloxicam
Similar Articles
